SplitJun 1, 2026, 09:08 AM
Silo Pharma Announces 1-for-15 Reverse Stock Split
AI Summary
Silo Pharma, Inc. announced a 1-for-15 reverse stock split of its issued and outstanding common stock, effective June 2, 2026, at 4:01 p.m. Eastern Time. Trading on a post-split basis will begin on The Nasdaq Capital Market on June 3, 2026, under the existing symbol "SILO". This action will reduce the current outstanding shares from approximately 16.267 million to 1.084 million, with proportionate adjustments to equity awards and warrants. Concurrently, the company's authorized common stock will be reduced to 6,666,667 shares.
Key Highlights
- Silo Pharma will effect a 1-for-15 reverse stock split.
- The reverse split is effective as of 4:01 p.m. ET on June 2, 2026.
- Post-split trading on Nasdaq will commence on June 3, 2026, under symbol "SILO".
- Outstanding shares will reduce from approximately 16.267 million to 1.084 million.
- Fractional shares will be rounded up to the next higher whole share.
- Authorized common stock will be reduced to 6,666,667 shares.
- The CUSIP number for common stock will change to 82711P 300.
Price Impact
More from SILO